A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection

NCT02498015 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

87

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: "3D" regimen
DRUG: "3D" regimen with ribavirin

Sponsor

Kirby Institute